Cargando…

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial

BACKGROUND: Cisplatin-radiotherapy is a preferred standard for locally advanced, head and neck squamous cell carcinoma (HNSCC). However, the cisplatin-attributable survival benefit is small and toxicity substantial. A biomarker of cisplatin resistance could guide treatment selection and spare morbid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauman, J E, Austin, M C, Schmidt, R, Kurland, B F, Vaezi, A, Hayes, D N, Mendez, E, Parvathaneni, U, Chai, X, Sampath, S, Martins, R G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798971/ https://www.ncbi.nlm.nih.gov/pubmed/24064970 http://dx.doi.org/10.1038/bjc.2013.576

Ejemplares similares

ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
por: Vaezi, Alec, et al.
Publicado: (2011)

Technical Advances and Pitfalls in Head and Neck Radiotherapy
por: Parvathaneni, Upendra, et al.
Publicado: (2012)

Association between Single Nucleotide Polymorphisms in ERCC4 and Risk of Squamous Cell Carcinoma of the Head and Neck
por: Yu, Hongping, et al.
Publicado: (2012)

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
por: Julian, Ricklie, et al.
Publicado: (2021)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
por: Lin, Alexander, et al.
Publicado: (2021)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population
por: Liu, Dabiao, et al.
Publicado: (2018)

Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer
por: Rao, Yuan James, et al.
Publicado: (2023)

Comparisons of 3-Dimensional Conformal and Intensity-Modulated Neutron Therapy for Head and Neck Cancers
por: Viscariello, Natalie, et al.
Publicado: (2021)

Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
por: Centuori, Sara M., et al.
Publicado: (2021)

Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?
por: Gao, Rui, et al.
Publicado: (2013)

Head and neck sarcomas: prognostic factors and implications for treatment.
por: Eeles, R. A., et al.
Publicado: (1993)

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer
por: Dudás, József, et al.
Publicado: (2014)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
por: Jones, Trace M., et al.
Publicado: (2021)

ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer
por: Choueiri, Michel B., et al.
Publicado: (2015)

The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development
por: Rouissi, Kamel, et al.
Publicado: (2011)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014)

Prognostic implications of peritumoral vasculature in head and neck cancer
por: Evans, Michael, et al.
Publicado: (2018)

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors
por: Pan, Cassie, et al.
Publicado: (2023)

The ERCC6 Gene and Age-Related Macular Degeneration
por: Baas, Dominique C., et al.
Publicado: (2010)

ERCC1 and ERCC2 Haplotype Modulates Induced BPDE-DNA Adducts in Primary Cultured Lymphocytes
por: Lu, Xiaobo, et al.
Publicado: (2013)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
por: Obiedat, Hadeel, et al.
Publicado: (2018)

Polymorphisms in ERCC2 and ERCC5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
por: Liu, Yi, et al.
Publicado: (2018)

Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer
por: Moslehi, Roxana, et al.
Publicado: (2020)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
por: Chen, Jing, et al.
Publicado: (2021)

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
por: Chiu, Tai-Jan, et al.
Publicado: (2011)

P795: CHARACTERIZATION OF ERCC6L2 SYNDROME PATIENTS’ TRANSCRIPTOME
por: Douglas, S. P., et al.
Publicado: (2022)

New Prognostic and Predictive Markers in Head and Neck Tumors
por: Cantile, Monica, et al.
Publicado: (2016)

Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer
por: Joo, Jungnam, et al.
Publicado: (2016)

Polymorphisms in ERCC4 and ERCC5 and risk of cancers: Systematic research synopsis, meta-analysis, and epidemiological evidence
por: Zuo, Chunjian, et al.
Publicado: (2022)

Interventions to improve quality of life (QOL) and/or mood in patients with head and neck cancer (HNC): a review of the evidence
por: Senchak, Jordan J., et al.
Publicado: (2019)

Head and Neck Melanoma
por: Shashanka, R., et al.
Publicado: (2012)

Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck
por: Cook, Maclean M., et al.
Publicado: (2020)

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.
por: Munro, A. J.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_d0sk9ttetnbmr6fi1qcqghf7bc